Arcturus Therapeutics Holdings (ARCT)
(Delayed Data from NSDQ)
$20.61 USD
-0.41 (-1.95%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $20.63 +0.02 (0.10%) 6:48 PM ET
1-Strong Buy of 5 1
D Value A Growth D Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/12/2024
Time: -- |
9/2024 | $-0.70 | 0.00% |
Earnings Summary
For their last quarter, Arcturus Therapeutics Holdings (ARCT) reported earnings of -$0.64 per share, beating the Zacks Consensus Estimate of $-1.85 per share. This reflects a positive earnings surprise of 65.41%. Look out for ARCT's next earnings release expected on November 12, 2024. For the next earning release, we expect the company to report earnings of -$0.70 per share, reflecting a year-over-year decrease of 14.75%.
Earnings History
Price & Consensus
Zacks News for ARCT
New Strong Buy Stocks for September 13th
ARCT: What are Zacks experts saying now?
Zacks Private Portfolio Services